A Multicenter Randomized Study Comparing the Dose Dense, G-CSF-Supported Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Women With Axillary Lymph Node Positive Breast Cancer
This trial will compare the dose dense, G-CSF supported sequential administration of 4
cycles of 5-Fluoruracil (F) plus Epirubicin (E 75mg/m2) plus Cyclofosfamide (C) followed by
4 cycles of docetaxel versus 4 cycles of paclitaxel as adjuvant chemotherapy in women with
axillary lymph node positive breast cancer
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
3-year disease-free survival
3 years
No
Dimitris Mavrudis, MD
Principal Investigator
University Hospital of Crete
Greece: National Organization of Medicines
CT/04.22
NCT00431080
August 2004
October 2007
Name | Location |
---|